Analysis and Impact of Formulated Herbal Medicine Against COVID-19 and Other Viral Infections

• Authors
• Authors and affiliations

ABSTRACT

Herbal drugs play significant role in the India and many parts of the world to cure many diseases and health complications. These drugs are used to treat viral, bacterial and many other microbial diseases viz. COVID-19, dengue, malaria, cancer and diabetes. Still herbal drug is not achieved prominent place in the health system. This study highlights the significant role of herbal medicine Chronheal-7 to cure COVID-19, dengue, malaria and other microbial infections. Chronheal-7, poly herbal medicine prepared from six different  herbs, G. glabra, P. niruri, S. xanthocarpum, B. diffusa, E. alba and W. somnifera. Chronheal-7 effect against SARS-CoV-2 is endorsed by In Vivo and In Vitro studies. Ayurvedic polyherbal formulation “Chronheal-7” has shown great potential against viral infections COVID-19 including dengue and chikungunya. The results obtained by In Vitro and In Vivo antiviral studies showed ‘Chronheal-7’ potential against SARS-CoV-2 virus. COVID-19, dengue and chikungunya infected patients cured by ‘Chronheal-7’ medicine. SARS-CoV-2 virus infected VeroE6 cell line assay showed anti-viral potential of ‘Chronheal-7’ (49.45% inhibition) after 30 h of incubation and cytotoxicity test showed non-toxicity for human cells. In Vitro and In Vivo studies showed ‘Chronheal-7’ medicine is effective against COVID-19 along with other viral infections viz. dengue, chikungunya. Chronheal-7 has great potential for management of COVID-19 and microbial aliments. It can be used as one of the immune-modular herbal drug in different viral infections. The authors claim that the Chronheal-7 is antiviral and antimicrobial herbal medicine. This study confirms the antiviral effects of Chronheal-7 on the key human pathogen SARS-CoV-2 and may be used as special drug to cure many viral, bacterial and fungal infections.

Significance of the study:

This study underscores the promising potential of Chronheal-7, a polyherbal medicine, in combating COVID-19 and other viral infections such as dengue and chikungunya. Highlighting its efficacy and safety in both In Vitro and In Vivo studies, Chronheal-7 emerges as a vital alternative to modern drugs, addressing the pressing need for effective, side-effect-free antiviral treatments.

Summary of the study:

Chronheal-7, a polyherbal formulation comprising G. glabra, P. niruri, S. xanthocarpum, B. diffusa, E. alba, and W. somnifera, demonstrated significant antiviral activity against SARS-CoV-2, dengue, and chikungunya. In Vitro and In Vivo studies revealed 49.45% SARS-CoV-2 inhibition and non-toxicity to human cells. Chronheal-7 reduced viral loads and severity in COVID-19 cases, showing potential as a broad-spectrum antiviral and antimicrobial agent.